Exploring the Latest Innovations in Antibiotics Market Size 2023 With Top Key Players: Pfizer Inc., Merck & Co. Inc.

Antibiotics Market Size

Antibiotics Market Size

Rise in consumption of antibiotics in low & middle-income countries (LMICs), heavy inflow of investments for R&D activities Drives the Market Growth

PUNE, MAHARASHTRA, INDIA, February 20, 2023 /EINPresswire.com/ -- Antibiotics are medications that are used to treat bacterial infections. They work by either killing the bacteria or stopping their growth. Antibiotics are widely used in the treatment of a variety of infections, including urinary tract infections, pneumonia, strep throat, and sinusitis. They can be administered orally, topically, or intravenously. It's important to note that antibiotics are not effective against viral infections, such as the common cold or the flu. Overuse of antibiotics can also lead to antibiotic resistance, where bacteria develop resistance to antibiotics, making them less effective.

Allied Market Research has published a study report with the title Antibiotics Market Size is Projected to Garner USD 50.37 billion by 2025, registering a CAGR of 2.1% During Forecast Period.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/5072

๐‚๐จ๐ฏ๐ข๐-๐Ÿ๐Ÿ— ๐’๐œ๐ž๐ง๐š๐ซ๐ข๐จ-

โ€ข The COVID-19 pandemic has had a mixed impact on the antibiotics market. On one hand, the increased focus on hygiene and infection control has led to increased demand for antibiotics to treat and prevent infections. However, on the other hand, the pandemic has also led to disruptions in the supply chain for antibiotics, as well as increased pressure to limit the use of antibiotics in COVID-19 patients to reduce the risk of antibiotic resistance.
โ€ข In some cases, the pandemic has also led to a decrease in demand for antibiotics, as hospital resources have been diverted to treating COVID-19 patients and elective surgeries have been postponed or cancelled.
โ€ข Overall, the impact of COVID-19 on the antibiotics market is complex and multifaceted, and is likely to vary depending on factors such as the type of antibiotic and the regional healthcare system.

๐–๐ก๐š๐ญ ๐€๐ซ๐ž ๐ญ๐ก๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐Ÿ๐จ๐ซ ๐€๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ?

The market drivers for antibiotics include the increasing incidence of infectious diseases, growing population, increasing resistance of pathogens to existing antibiotics, and the development of innovative antibiotics with improved efficacy and fewer side effects. Additionally, the rising demand for antibiotics in emerging economies and the increasing investment by pharmaceutical companies in R&D for the development of novel antibiotics are also significant market drivers. The increasing prevalence of chronic diseases and the growth of the elderly population further fuel the demand for antibiotics. Finally, the initiatives taken by government organizations to promote the rational use of antibiotics and prevent the emergence of antibiotic resistance are also important market drivers.

๐“๐จ๐ฉ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐€๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ

โ€ข Pfizer Inc.
โ€ข Merck & Co. Inc.
โ€ข Novartis AG
โ€ข GlaxoSmithKline plc
โ€ข AstraZeneca plc
โ€ข Sanofi S.A.
โ€ข Eli Lilly and Company
โ€ข Johnson & Johnson
โ€ข Allergan plc
โ€ข Bayer AG.

๐€๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐œ๐š๐ง ๐›๐ž ๐๐จ๐ง๐ž ๐›๐š๐ฌ๐ž๐ ๐จ๐ง ๐ฌ๐ž๐ฏ๐ž๐ซ๐š๐ฅ ๐Ÿ๐š๐œ๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐œ๐ฅ๐ฎ๐๐ข๐ง๐ :

The antibiotics market can be segmented based on drug class, the spectrum of activity, route of administration, distribution channel, and geography.

By Drug class:

โ€ข Beta-lactams (penicillins, cephalosporins, carbapenems)
โ€ข Macrolides
โ€ข Quinolones
โ€ข Tetracyclines
โ€ข Aminoglycosides
โ€ข Sulfonamides
โ€ข Others (oxazolidinones, polymyxins, lincosamides)

By spectrum of activity:

โ€ข Broad-spectrum antibiotics
โ€ข Narrow-spectrum antibiotics

By Route of Administration:

โ€ข Oral
โ€ข Intravenous
โ€ข Others (topical, subcutaneous, intramuscular)

By distribution channel:

โ€ข Hospital pharmacies
โ€ข Retail pharmacies
โ€ข Online pharmacies

Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/5072

Our Market Research Solution Provides You Answer to Below Mentioned Question:

โ€ข Which are the driving factors responsible for the growth of market?
โ€ข Which are the roadblock factors of this market?
โ€ข What are the new opportunities, by which market will grow in coming years?
โ€ข What are the trends of this market?
โ€ข Which are main factors responsible for new product launch?
โ€ข How big is the global & regional market in terms of revenue, sales and production?
โ€ข How far will the market grow in forecast period in terms of revenue, sales and production?
โ€ข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โ€ข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โ€ข Which region has more opportunities?

By Region Outlook

โ€ข North America
(U.S., Canada, Mexico)
โ€ข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โ€ข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โ€ข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Top Trending Report:

Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market
3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market
Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market
Digital Pathology Market: https://www.alliedmarketresearch.com/digital-pathology-market

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

David Correa
Allied Analytics LLP
+ +1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.